News
15h
Stockhead on MSNDr Boreham’s Crucible: Clarity is a clear and strong contender in the prostate cancer treatment race
There’s nothing like a great biotech rivalry, such as the one between radio-pharmaceutical peers Clarity Pharmaceuticals (ASX ...
Evolve Genomix is expanding genomic testing access, developing rapid diagnostics and securing NSF SBIR funding for innovation ...
20h
AZoM on MSNArchaeometry: Unveiling the Past with Future-Ready Tools
Mary Kate Donais discusses the evolution of portable analytical techniques in archaeometry, enhancing our understanding of cultural heritage through chemistry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results